Russell Investments Group, Ltd. Regenxbio Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 28,281 shares of RGNX stock, worth $234,449. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,281

Previous 18,989 48.93%

Holding current value

$234,449

Previous $222,000 33.33%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.49 - $14.39 $97,473 - $133,711	9,292 Added 48.93%	28,281 $296,000
Q2 2024 Aug 08, 2024	BUY	$11.51 - $21.53 $121,165 - $226,646	10,527 Added 124.4%	18,989 $222,000
Q1 2024 May 08, 2024	SELL	$12.17 - $24.61 $389,719 - $788,086	-32,023 Reduced 79.1%	8,462 $178,000
Q4 2023 Feb 05, 2024	BUY	$12.89 - $20.82 $3,750 - $6,058	291 Added 0.72%	40,485 $726,000
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $16,246 - $19,730	-987 Reduced 2.4%	40,194 $661,000
Q2 2023 Aug 10, 2023	SELL	$17.23 - $21.71 $182,000 - $229,322	-10,563 Reduced 20.41%	41,181 $823,000
Q1 2023 May 09, 2023	BUY	$18.08 - $24.55 $924,177 - $1.25 Million	51,116 Added 8139.49%	51,744 $978,000
Q3 2022 Nov 04, 2022	SELL	$22.29 - $35.04 $336,846 - $529,524	-15,112 Reduced 96.01%	628 $16,000
Q2 2022 Jul 29, 2022	SELL	$19.35 - $35.04 $44,892 - $81,292	-2,320 Reduced 12.85%	15,740 $388,000
Q1 2022 May 05, 2022	BUY	$24.62 - $34.31 $406,623 - $566,663	16,516 Added 1069.69%	18,060 $598,000
Q3 2021 Nov 08, 2021	SELL	$29.09 - $45.68 $895,186 - $1.41 Million	-30,773 Reduced 95.22%	1,544 $64,000
Q2 2021 Aug 04, 2021	SELL	$32.46 - $40.48 $68,945 - $85,979	-2,124 Reduced 6.17%	32,317 $1.25 Million
Q1 2021 May 10, 2021	BUY	$33.61 - $49.95 $113,198 - $168,231	3,368 Added 10.84%	34,441 $1.17 Million
Q4 2020 Feb 08, 2021	BUY	$26.52 - $49.35 $626,879 - $1.17 Million	23,638 Added 317.93%	31,073 $1.41 Million
Q3 2020 Nov 09, 2020	BUY	$27.01 - $40.26 $163,005 - $242,969	6,035 Added 431.07%	7,435 $204,000
Q2 2020 Aug 05, 2020	BUY	$27.75 - $43.44 $38,850 - $60,816	1,400 New	1,400 $51,000
Q4 2019 Jan 29, 2020	SELL	$34.54 - $44.87 $1.57 Million - $2.04 Million	-45,448 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$31.84 - $50.88 $84,312 - $134,730	-2,648 Reduced 5.51%	45,448 $1.62 Million
Q2 2019 Aug 09, 2019	SELL	$42.0 - $59.29 $714,000 - $1.01 Million	-17,000 Reduced 26.12%	48,096 $2.47 Million
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $1.56 Million - $2.38 Million	38,120 Added 141.31%	65,096 $3.67 Million
Q4 2018 Feb 11, 2019	SELL	$39.11 - $75.15 $1.17 Million - $2.25 Million	-29,916 Reduced 52.58%	26,976 $1.13 Million
Q3 2018 Oct 26, 2018	BUY	$65.0 - $82.15 $3.56 Million - $4.49 Million	54,695 Added 2489.53%	56,892 $4.3 Million
Q2 2018 Aug 08, 2018	BUY	$27.2 - $74.35 $59,758 - $163,346	2,197 New	2,197 $157,000

Others Institutions Holding RGNX

# of Institutions

195

Shares Held

42.9M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $358M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Regenxbio Inc. Transaction History